These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11090066)

  • 1. Endogenous biosynthesis of thromboxane and prostacyclin in 2 distinct murine models of atherosclerosis.
    Praticò D; Cyrus T; Li H; FitzGerald GA
    Blood; 2000 Dec; 96(12):3823-6. PubMed ID: 11090066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The thromboxane receptor antagonist S18886 but not aspirin inhibits atherogenesis in apo E-deficient mice: evidence that eicosanoids other than thromboxane contribute to atherosclerosis.
    Cayatte AJ; Du Y; Oliver-Krasinski J; Lavielle G; Verbeuren TJ; Cohen RA
    Arterioscler Thromb Vasc Biol; 2000 Jul; 20(7):1724-8. PubMed ID: 10894809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic effects of oral prostacyclin analogue on thromboxane A2 and prostacyclin metabolites in pulmonary hypertension.
    Ichida F; Uese K; Hamamichi Y; Hashimoto I; Tsubata S; Fukahara K; Murakami A; Miyawaki T
    Acta Paediatr Jpn; 1998 Feb; 40(1):14-9. PubMed ID: 9583194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic dietary supplementation with L-arginine inhibits platelet aggregation and thromboxane A2 synthesis in hypercholesterolaemic rabbits in vivo.
    Bode-Böger SM; Böger RH; Kienke S; Böhme M; Phivthong-ngam L; Tsikas D; Frölich JC
    Cardiovasc Res; 1998 Mar; 37(3):756-64. PubMed ID: 9659460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of thromboxane and prostacyclin metabolites during chronic low-dose aspirin: evidence for an extrarenal origin of urinary thromboxane B2 and 6-keto-prostaglandin F1 alpha in healthy subjects.
    Chiabrando C; Rivoltella L; Martelli L; Valzacchi S; Fanelli R
    Biochim Biophys Acta; 1992 Feb; 1133(3):247-54. PubMed ID: 1737057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase.
    Reilly IA; Doran JB; Smith B; FitzGerald GA
    Circulation; 1986 Jun; 73(6):1300-9. PubMed ID: 2938849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid peroxidation and platelet activation in murine atherosclerosis.
    Cyrus T; Tang LX; Rokach J; FitzGerald GA; Praticò D
    Circulation; 2001 Oct; 104(16):1940-5. PubMed ID: 11602498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
    Tohgi H; Konno S; Tamura K; Kimura B; Kawano K
    Stroke; 1992 Oct; 23(10):1400-3. PubMed ID: 1412574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis.
    Belton O; Byrne D; Kearney D; Leahy A; Fitzgerald DJ
    Circulation; 2000 Aug; 102(8):840-5. PubMed ID: 10952950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prostacyclin production during exercise in untrained and trained men: effect of low-dose aspirin.
    Böger RH; Bode-Böger SM; Schröder EP; Tsikas D; Frölich JC
    J Appl Physiol (1985); 1995 May; 78(5):1832-8. PubMed ID: 7649919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
    FitzGerald GA; Oates JA; Hawiger J; Maas RL; Roberts LJ; Lawson JA; Brash AR
    J Clin Invest; 1983 Mar; 71(3):676-88. PubMed ID: 6338043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary 11-dehydro-thromboxane B₂ and 2,3-dinor-6-keto-prostaglandin-F₁α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg.
    Hartanto MD; Arieselia Z; Setiabudy R; Setiawati A; Baziad A
    J Thromb Thrombolysis; 2012 Jul; 34(1):79-84. PubMed ID: 22311294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective and nonselective inhibition of thromboxane formation.
    FitzGerald GA; Oates JA
    Clin Pharmacol Ther; 1984 May; 35(5):633-40. PubMed ID: 6370554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities in the biosynthesis of thromboxane A2 and prostacyclin in children with cyanotic congenital heart disease.
    Adatia I; Barrow SE; Stratton P; Ritter JM; Haworth SG
    Br Heart J; 1993 Feb; 69(2):179-82. PubMed ID: 8435245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet function and biosynthesis of prostacyclin and thromboxane A2 in whole blood after aspirin administration in human subjects.
    Mehta JL; Mehta P; Lopez L; Ostrowski N; Aguila E
    J Am Coll Cardiol; 1984 Oct; 4(4):806-11. PubMed ID: 6384329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
    Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
    Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause.
    Jendryczko A; Tomala J
    Zentralbl Gynakol; 1993; 115(4):163-6. PubMed ID: 8503234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional significance of renal prostacyclin and thromboxane A2 production in patients with systemic lupus erythematosus.
    Patrono C; Ciabattoni G; Remuzzi G; Gotti E; Bombardieri S; Di Munno O; Tartarelli G; Cinotti GA; Simonetti BM; Pierucci A
    J Clin Invest; 1985 Sep; 76(3):1011-8. PubMed ID: 3900132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the infusion of OKY-046, a thromboxane A2 synthase inhibitor, on urinary metabolites of prostacyclin and thromboxane A2 in healthy human subjects.
    Morio H; Hirai A; Terano T; Tamura Y; Yoshida S
    Thromb Haemost; 1993 Mar; 69(3):276-81. PubMed ID: 8470052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of microsomal prostaglandin E synthase-1 augments prostacyclin and retards atherogenesis.
    Wang M; Zukas AM; Hui Y; Ricciotti E; Puré E; FitzGerald GA
    Proc Natl Acad Sci U S A; 2006 Sep; 103(39):14507-12. PubMed ID: 16973753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.